Biotech Values

[DewDiligence]

FDA-review factoids:

http://online.wsj.com/article/SB10001424052702303365804576432170845403108.html

[CDER head, Janet] Woodcock explained the agency meets more than 90% of deadlines that are part of the drug-review process. She also said so-called first cycle approvals are at a 20-year high with and said more than two-thirds of new drugs being approved within the six-to-10-month time frames given to new drug applications.